This section describes Zepbound’s typical dosage, but always follow the dosage your doctor prescribes. Form and strengths Zepbound comes as a liquid solution in prefilled, disposable injection ...

The FDA gave Zepbound “fast track” approval to study its uses for overweight or obese adults with comorbidities like sleep apnea in 2022, around when weight-loss drugs began growing in popularity.

For more information, you can refer to Zepbound’s prescribing information. If you develop serious side effects while receiving Zepbound, call your doctor right away.

And do not stop using Zepbound unless your doctor recommends it. Zepbound may cause mild side effects other than those listed previously. See the drug’s prescribing information for details.

How Does Zepbound Reduce Weight? Tirzepatide works by activating two proteins called glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) which belong to a group ...

Separate studies conducted by the respective manufacturers have showed that Zepbound, with its dual-acting effect, was linked to more weight loss than Wegovy, but until now, no studies have ...

An obesity drug called Zepbound won approval for use in adults from the Food and Drug Administration Wednesday, ushering in a new rival to Novo Nordisk's blockbuster Wegovy. Eli Lilly & Co., maker ...

FDA approves Zepbound, a new obesity drug that will take on Wegovy The FDA approval comes amid growing discussion about the potential uses of weight loss drugs beyond treating obesity and diabetes.

Nearly 32% of Zepbound users ultimately lost at least a quarter of their body weight, compared with just 16% of Wegovy users. In both groups, weight loss was about 6% lower in men than in women.

According to a study funded by Eli Lilly, the trial revealed that participants taking tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds, while those who took semaglutide, or ...

Texas Attorney General Ken Paxton has filed a lawsuit against Eli Lilly and Co. (NYSE:LLY), accusing the pharmaceutical giant ...